Outset Medical to Present at Upcoming Investor Conferences

Rhea-AI Summary

Outset Medical, Inc. (Nasdaq: OM) has announced management participation in two investor conferences. The UBS Global Healthcare Conference will take place on May 24, 2022, at 4:45am PT, while the Goldman Sachs 43rd Annual Global Healthcare Conference is set for June 14, 2022, at 3:20pm PT. A live and archived webcast of these fireside chats will be available on Outset's investor website. Outset continues to innovate with its Tablo Hemodialysis System, designed to enhance dialysis care accessibility and efficiency.

SAN JOSE, Calif.--(BUSINESS WIRE)-- Outset Medical, Inc. (Nasdaq: OM) (“Outset”), a medical technology company pioneering a first-of-its-kind technology to reduce the cost and complexity of dialysis, today announced that members of management will participate in fireside chats at two upcoming investor conferences. Outset will participate in the 2022 UBS Global Healthcare Conference on Tuesday, May 24, 2022 and the Goldman Sachs 43^rd Annual Global Healthcare Conference on Tuesday, June 14, 2022.

Event: 2022 UBS Global Healthcare Conference
Date: Tuesday, May 24, 2022
Time: 4:45am PT / 7:45am ET

Event: Goldman Sachs 43^rd Annual Global Healthcare Conference
Date: Tuesday, June 14, 2022
Time: 3:20pm PT / 6:20pm ET

A live and archived webcast of the fireside chats will be available on the “Investors” section of the Outset website at https://investors.outsetmedical.com/.

About Outset Medical, Inc.

Outset is a medical technology company pioneering a first-of-its-kind technology to reduce the cost and complexity of dialysis. The Tablo Hemodialysis System, FDA cleared for use from the hospital to the home, represents a significant technological advancement that transforms the dialysis experience for patients and operationally simplifies it for providers. Tablo serves as a single enterprise solution that can be utilized across the continuum of care, allowing dialysis to be delivered anytime, anywhere and by anyone. The integration of water purification and on-demand dialysate production enables Tablo to serve as a dialysis clinic on wheels, with 2-way wireless data transmission and a proprietary data analytics platform powering a new holistic approach to dialysis care. Tablo is a registered trademark of Outset Medical, Inc.

View source version on businesswire.com: https://www.businesswire.com/news/home/20220518005744/en/

Jim Mazzola

Vice President, Investor Relations

jmazzola@outsetmedical.com

Brian Johnston

Gilmartin Group

(332) 895-3222

investors@outsetmedical.com

Source: Outset Medical, Inc.

FAQ

When will Outset Medical participate in the UBS Global Healthcare Conference?

Outset Medical will participate in the UBS Global Healthcare Conference on May 24, 2022, at 4:45am PT.

What is the date and time of Outset Medical's participation in the Goldman Sachs conference?

Outset Medical will participate in the Goldman Sachs 43rd Annual Global Healthcare Conference on June 14, 2022, at 3:20pm PT.

Where can I find a webcast of Outset Medical's investor conference chats?

A live and archived webcast can be found on the Investors section of Outset Medical's website.

What is the significance of Outset Medical's Tablo Hemodialysis System?

Tablo is designed to reduce the cost and complexity of dialysis, providing a versatile solution for patient care.